CompletedNot applicableNCT03958253
Official study title

Lung Cancer Screening Protocol

Study summary

The successful implementation of lung cancer screening across diverse setting requires working with the community and primary care practices. Collaborating across diverse community-based sites will employ local knowledge and culture in the understanding of the health problem and identifying and implementing solutions that are appropriate for all partners (patients, primary care, referral centers). Enhanced, culturally-competent communication with patients at high risk for lung cancer can narrow inequities in screening awareness, referral, and utilization, as well as improve lung cancer outcomes across diverse patients and communities. Promoting partnerships among physicians, staff, and patients; creating routines; and tailoring materials to each clinician's situation have been show to increase the proportion of patients receiving screening.

Ask AI to explain this study
Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedToolbox for Lung Cancer Screening

The study team can explain what participation involves.

Who it may be forLung Cancer Screening

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Apr 8, 2021 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?7 U.S. locations

Locations may change over time.

Who runs it?Washington University School of Medicine

Study sponsor

01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
Washington University School of Medicine
Interventions being studied
Other: Toolbox for Lung Cancer Screening
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • To be eligible to participate in the trial, screening centers have to be existing members of the BJC Collaborative.
  • Primary Care Providers have to have a referral relationship with the screening center; serve adult patients who may be screening-eligible, and are willing to interact with the referral site to implement referral for LDCT.
Reasons someone may not be able to joinExclusion criteria

There are not any

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Southern Illinois HealthcareCarbondale, Illinois
  • Decatur Memorial HospitalDecatur, Illinois
  • Sarah Bush Lincoln Health SystemMattoon, Illinois
  • Memorial Health SystemSpringfield, Illinois
  • BJC HealthCare, Barnes-Jewish St. Peters HospitalCity of Saint Peters, Missouri
  • CoxHealthSpringfield, Missouri
  • Washington University School of MedicineSt Louis, Missouri

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 8, 2021. Always confirm current availability with the study team.

View original record ↗